Status:
COMPLETED
Drug Use During Sex and Its Impact on Taking PrEP (Pre-Exposure Prophylaxis) : CONSUME
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Conditions:
Drug Dependence
Eligibility:
MALE
18+ years
Brief Summary
This is a cross-sectional, single-center observational study conducted from October 2020 to March 2021 in Ile de France at the infectious disease of CHU Bichat (PrEP and CeGIDD(Free Center for Informa...
Eligibility Criteria
Inclusion
- age\> 18
- male or transgender
- MSM or bi-sexual orientation
- adult consultant at Bichat Hospital (CeGIDD or PrEP consultation)
- adult with a Smartphone (online self-questionnaire)
Exclusion
- For the group "taking PrEP": adult taking PrEP for less than 3 months
- Refusal of participation
Key Trial Info
Start Date :
March 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
March 25 2022
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04709016
Start Date
March 18 2021
End Date
March 25 2022
Last Update
August 30 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
SMIT - Hôpital Bichat
Paris, France, 75018